MedPath

BIOFIRST CORPORATION

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE)

Not Applicable
Suspended
Conditions
Retinal Detachment
Interventions
Device: ABV-1701
Device: SF6 Gas
First Posted Date
2022-06-10
Last Posted Date
2023-11-18
Lead Sponsor
BioFirst Corporation
Target Recruit Count
40
Registration Number
NCT05414747
Locations
🇦🇺

East Melbourne Eye Group, Melbourne, Victoria, Australia

🇹🇭

Ramathibodi Hospital, Bangkok, Thailand

🇦🇺

Sydney Eye Hospital, Syd, New South Wales, Australia

and more 1 locations

A Phase I Study of Vitargus® in Vitrectomy

Not Applicable
Completed
Conditions
Vitreo-retinal Surgery
Interventions
Device: Vitargus, BFC-1401
First Posted Date
2020-07-22
Last Posted Date
2020-09-09
Lead Sponsor
BioFirst Corporation
Target Recruit Count
11
Registration Number
NCT04481386
Locations
🇦🇺

Sydney Retina Clinic and Day Surgery, Sydney, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath